U.S. markets close in 1 hour 44 minutes
  • S&P 500

    4,158.60
    +42.92 (+1.04%)
     
  • Dow 30

    34,109.07
    +213.03 (+0.63%)
     
  • Nasdaq

    13,513.31
    +213.58 (+1.61%)
     
  • Russell 2000

    2,193.26
    -0.38 (-0.02%)
     
  • Crude Oil

    61.99
    -1.37 (-2.16%)
     
  • Gold

    1,877.30
    -4.20 (-0.22%)
     
  • Silver

    27.93
    -0.09 (-0.32%)
     
  • EUR/USD

    1.2222
    +0.0040 (+0.33%)
     
  • 10-Yr Bond

    1.6350
    -0.0480 (-2.85%)
     
  • GBP/USD

    1.4184
    +0.0071 (+0.51%)
     
  • USD/JPY

    108.8020
    -0.3670 (-0.34%)
     
  • BTC-USD

    39,393.29
    +952.11 (+2.48%)
     
  • CMC Crypto 200

    1,036.79
    +39.57 (+3.97%)
     
  • FTSE 100

    7,019.79
    +69.59 (+1.00%)
     
  • Nikkei 225

    28,098.25
    +53.80 (+0.19%)
     

LAWSUITS FILED AGAINST KDMN, EBON and DOX - Jakubowitz Law Pursues Shareholders Claims

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

NEW YORK, NY / ACCESSWIRE / May 20, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. For more details and to speak with our firm without cost or obligation, follow the links below.

Kadmon Holdings, Inc. (NASDAQ:KDMN)

CONTACT JAKUBOWITZ ABOUT KDMN:
https://claimyourloss.com/securities/kadmon-holdings-inc-loss-submission-form/?id=15985&from=1

Class Period : October 1, 2020 - March 10, 2021

Lead Plaintiff Deadline : June 2, 2021

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) the Belumosudil NDA was incomplete and/or deficient; (ii) the additional new data that the Company submitted in support of the Belumosudil NDA in response to an information request from the FDA materially altered the NDA submission; (iii) accordingly, the initial Belumosudil NDA submission lacked the degree of support that the Company had led investors to believe; (iv) accordingly, the FDA was likely to extend the PDUFA target action date to review the Belumosudil NDA; and (v) as a result, the Company's public statements were materially false and misleading at all relevant times.

Ebang International Holdings Inc. (NASDAQ:EBON)

CONTACT JAKUBOWITZ ABOUT EBON:
https://claimyourloss.com/securities/ebang-international-holdings-inc-loss-submission-form/?id=15985&from=1

Class Period : June 26, 2020 - April 5, 2021

Lead Plaintiff Deadline : June 7, 2021

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) the proceeds from Ebang's public offerings had been directed to an low yield, long term bonds to an underwriter and to related parties rather than used to develop the Company's operations; (2) Ebang's sales were declining and the Company had inflated reported sales, including through the sale of defective units; (3) Ebang's attempts to go public in Hong Kong had failed due to allegations of embezzling investor funds and inflated sales figures; (4) Ebang's purported crytocurrency exchange was merely the purchase of an out-of-the-box crypto exchange; and (5) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Amdocs Limited (NASDAQ:DOX)

CONTACT JAKUBOWITZ ABOUT DOX:
https://claimyourloss.com/securities/amdocs-limited-loss-submission-form/?id=15985&from=1

Class Period : December 13, 2016 - March 30, 2021

Lead Plaintiff Deadline : June 8, 2021

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) Amdocs overstated its profits, cash, and liquidity, while understating its debt; (ii) Amdocs concealed its large borrowing; (iii) while Amdocs' reported results showed that its North American business was stable, that business was actually deteriorating annually, in part because the Company was losing AT&T as a customer; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (212) 867-4490
F: (212) 537-5887

SOURCE: Jakubowitz Law



View source version on accesswire.com:
https://www.accesswire.com/648430/LAWSUITS-FILED-AGAINST-KDMN-EBON-and-DOX--Jakubowitz-Law-Pursues-Shareholders-Claims